News & Updates

Show Multimedia Only

APOLLO: SC daratumumab an effective, convenient option in R/R MM

16 Dec 2020 by

Subcutaneous (SC) daratumumab in combination with pomalidomide and dexamethasone (Pd) improves progression-free survival (PFS) and achieves deeper responses vs Pd alone in patients with relapsed/refractory multiple myeloma (R/R MM), results of the phase III APOLLO trial have shown.

APOLLO: SC daratumumab an effective, convenient option in R/R MM

16 Dec 2020

Dairy may be protective against colorectal cancer

16 Dec 2020

Consuming high amounts of dairy may be beneficial, leading to a lower incidence of colorectal cancer and related mortality, according to a study.

Dairy may be protective against colorectal cancer

16 Dec 2020

Adjuvant radiotherapy not recommended after radical prostatectomy

15 Dec 2020 by

In men with prostate cancer who underwent radical prostatectomy (RP), adjuvant radiotherapy (RT) showed no benefit in terms of PSA* biochemical progression and increases the risk of urinary morbidity compared with salvage RT, the RADICALS**-RT trial suggests.

Adjuvant radiotherapy not recommended after radical prostatectomy

15 Dec 2020

News & Updates

Showing Oncology articles

Showing

Specialty:

APOLLO: SC daratumumab an effective, convenient option in R/R MM

APOLLO: SC daratumumab an effective, convenient option in R/R MM

Dairy may be protective against colorectal cancer

Dairy may be protective against colorectal cancer

Adjuvant radiotherapy not recommended after radical prostatectomy

Adjuvant radiotherapy not recommended after radical prostatectomy